Literature DB >> 18483185

Hepatocyte nuclear factor-4alpha is a central transactivator of the mouse Ntcp gene.

Andreas Geier1, Ina V Martin, Christoph G Dietrich, Natarajan Balasubramaniyan, Sonja Strauch, Frederick J Suchy, Carsten Gartung, Christian Trautwein, Meenakshisundaram Ananthanarayanan.   

Abstract

Sodium taurocholate cotransporting polypeptide (Ntcp) is the major uptake system for conjugated bile acids. Deletions of hepatocyte nuclear factor (HNF)-1alpha and retinoid X receptor-alpha:retinoic acid receptor-alpha binding sites in the mouse 5'-flanking region corresponding to putatively central regulatory elements of rat Ntcp do not significantly reduce promoter activity. We hypothesized that HNF-4alpha, which is increasingly recognized as a central regulator of hepatocyte function, may directly transactivate mouse (mNtcp). A 1.1-kb 5'-upstream region including the mouse Ntcp promoter was cloned and compared with the rat promoter. In contrast to a moderate 3.5-fold activation of mNtcp by HNF-1alpha, HNF-4alpha cotransfection led to a robust 20-fold activation. Deletion analysis of mouse and rat Ntcp promoters mapped a conserved HNF-4alpha consensus site at -345/-326 and -335/-316 bp, respectively. p-475bpmNtcpLUC is not transactivated by HNF-1alpha but shows a 50-fold enhanced activity upon cotransfection with HNF-4alpha. Gel mobility shift assays demonstrated a complex of the HNF-4alpha-element formed with liver nuclear extracts that was blocked by an HNF-4alpha specific antibody. HNF-4alpha binding was confirmed by chromatin immunoprecipitation. Using Hepa 1-6 cells, HNF-4alpha-knockdown resulted in a significant 95% reduction in NTCP mRNA. In conclusion, mouse Ntcp is regulated by HNF-4alpha via a conserved distal cis-element independently of HNF-1alpha.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18483185      PMCID: PMC2519858          DOI: 10.1152/ajpgi.00012.2008

Source DB:  PubMed          Journal:  Am J Physiol Gastrointest Liver Physiol        ISSN: 0193-1857            Impact factor:   4.052


  30 in total

1.  Hepatocyte nuclear factor-1alpha is an essential regulator of bile acid and plasma cholesterol metabolism.

Authors:  D Q Shih; M Bussen; E Sehayek; M Ananthanarayanan; B L Shneider; F J Suchy; S Shefer; J S Bollileni; F J Gonzalez; J L Breslow; M Stoffel
Journal:  Nat Genet       Date:  2001-04       Impact factor: 38.330

2.  The orphan nuclear receptor, shp, mediates bile acid-induced inhibition of the rat bile acid transporter, ntcp.

Authors:  L A Denson; E Sturm; W Echevarria; T L Zimmerman; M Makishima; D J Mangelsdorf; S J Karpen
Journal:  Gastroenterology       Date:  2001-07       Impact factor: 22.682

3.  Hepatocyte nuclear factor 4alpha (nuclear receptor 2A1) is essential for maintenance of hepatic gene expression and lipid homeostasis.

Authors:  G P Hayhurst; Y H Lee; G Lambert; J M Ward; F J Gonzalez
Journal:  Mol Cell Biol       Date:  2001-02       Impact factor: 4.272

4.  Control of hepatic gluconeogenesis through the transcriptional coactivator PGC-1.

Authors:  J C Yoon; P Puigserver; G Chen; J Donovan; Z Wu; J Rhee; G Adelmant; J Stafford; C R Kahn; D K Granner; C B Newgard; B M Spiegelman
Journal:  Nature       Date:  2001-09-13       Impact factor: 49.962

5.  Polyunsaturated fatty acyl coenzyme A suppress the glucose-6-phosphatase promoter activity by modulating the DNA binding of hepatocyte nuclear factor 4 alpha.

Authors:  Fabienne Rajas; Amandine Gautier; Isabelle Bady; Sandrine Montano; Gilles Mithieux
Journal:  J Biol Chem       Date:  2002-02-25       Impact factor: 5.157

Review 6.  Peroxisome proliferator-activated receptor-gamma coactivator 1 alpha (PGC-1 alpha): transcriptional coactivator and metabolic regulator.

Authors:  Pere Puigserver; Bruce M Spiegelman
Journal:  Endocr Rev       Date:  2003-02       Impact factor: 19.871

7.  Intraabdominal sepsis down-regulates transcription of sodium taurocholate cotransporter and multidrug resistance-associated protein in rats.

Authors:  P K Kim; J Chen; K M Andrejko; C S Deutschman
Journal:  Shock       Date:  2000-08       Impact factor: 3.454

8.  Genetic evidence that HNF-1alpha-dependent transcriptional control of HNF-4alpha is essential for human pancreatic beta cell function.

Authors:  Sara K Hansen; Marcelina Párrizas; Maria L Jensen; Stepanka Pruhova; Jakob Ek; Sylvia F Boj; Anders Johansen; Miguel A Maestro; Francisca Rivera; Hans Eiberg; Michal Andel; Jan Lebl; Oluf Pedersen; Jorge Ferrer; Torben Hansen
Journal:  J Clin Invest       Date:  2002-09       Impact factor: 14.808

9.  Hepatobiliary organic anion transporters are differentially regulated in acute toxic liver injury induced by carbon tetrachloride.

Authors:  Andreas Geier; Suk Kyum Kim; Thomas Gerloff; Christoph G Dietrich; Frank Lammert; Saul J Karpen; Bruno Stieger; Peter J Meier; Siegfried Matern; Carsten Gartung
Journal:  J Hepatol       Date:  2002-08       Impact factor: 25.083

10.  The orphan nuclear receptor HNF4alpha determines PXR- and CAR-mediated xenobiotic induction of CYP3A4.

Authors:  Rommel G Tirona; Wooin Lee; Brenda F Leake; Lu-Bin Lan; Cynthia Brimer Cline; Vishal Lamba; Fereshteh Parviz; Stephen A Duncan; Yusuke Inoue; Frank J Gonzalez; Erin G Schuetz; Richard B Kim
Journal:  Nat Med       Date:  2003-01-06       Impact factor: 53.440

View more
  14 in total

1.  Differential transcriptional characteristics of small and large biliary epithelial cells derived from small and large bile ducts.

Authors:  S Glaser; M Wang; Y Ueno; J Venter; K Wang; H Chen; G Alpini; A Holterman
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2010-06-24       Impact factor: 4.052

Review 2.  Nuclear receptors, inflammation, and liver disease: insights for cholestatic and fatty liver diseases.

Authors:  M Arrese; S J Karpen
Journal:  Clin Pharmacol Ther       Date:  2010-03-03       Impact factor: 6.875

3.  Dysregulation of retinoic acid receptor diminishes hepatocyte permissiveness to hepatitis B virus infection through modulation of sodium taurocholate cotransporting polypeptide (NTCP) expression.

Authors:  Senko Tsukuda; Koichi Watashi; Masashi Iwamoto; Ryosuke Suzuki; Hideki Aizaki; Maiko Okada; Masaya Sugiyama; Soichi Kojima; Yasuhito Tanaka; Masashi Mizokami; Jisu Li; Shuping Tong; Takaji Wakita
Journal:  J Biol Chem       Date:  2014-12-30       Impact factor: 5.157

4.  Histone H3K4 trimethylation by MLL3 as part of ASCOM complex is critical for NR activation of bile acid transporter genes and is downregulated in cholestasis.

Authors:  M Ananthanarayanan; Yanfeng Li; S Surapureddi; N Balasubramaniyan; Jaeyong Ahn; J A Goldstein; Frederick J Suchy
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2011-02-17       Impact factor: 4.052

Review 5.  Bile acid transporters.

Authors:  Paul A Dawson; Tian Lan; Anuradha Rao
Journal:  J Lipid Res       Date:  2009-06-04       Impact factor: 5.922

6.  Role of AMP-activated protein kinase α1 in 17α-ethinylestradiol-induced cholestasis in rats.

Authors:  Xiaojiaoyang Li; Runping Liu; Lan Luo; Linxi Yu; Xin Chen; Lixin Sun; Tao Wang; Phillip B Hylemon; Huiping Zhou; Zhenzhou Jiang; Luyong Zhang
Journal:  Arch Toxicol       Date:  2016-04-18       Impact factor: 5.153

Review 7.  Xenobiotic, bile acid, and cholesterol transporters: function and regulation.

Authors:  Curtis D Klaassen; Lauren M Aleksunes
Journal:  Pharmacol Rev       Date:  2010-01-26       Impact factor: 25.468

Review 8.  The functional role of sodium taurocholate cotransporting polypeptide NTCP in the life cycle of hepatitis B, C and D viruses.

Authors:  Carla Eller; Laura Heydmann; Che C Colpitts; Eloi R Verrier; Catherine Schuster; Thomas F Baumert
Journal:  Cell Mol Life Sci       Date:  2018-08-10       Impact factor: 9.207

Review 9.  Clinical application of transcriptional activators of bile salt transporters.

Authors:  Anna Baghdasaryan; Peter Chiba; Michael Trauner
Journal:  Mol Aspects Med       Date:  2013-12-12

10.  Down-regulation of NTCP expression by cyclin D1 in hepatitis B virus-related hepatocellular carcinoma has clinical significance.

Authors:  Jingting Kang; Jie Wang; Jin Cheng; Zhiliang Cao; Ran Chen; Huiyu Li; Shuang Liu; Xiangmei Chen; Jianhua Sui; Fengmin Lu
Journal:  Oncotarget       Date:  2016-06-23
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.